Zouambia M - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers.

Sayad M, Zouambia M, Chaouch M, Ferrat F, Nebbal M, Bendini M, Lesage S, Brice A, Brahim Errahmani M, Asselah B. Sayad M, et al. Among authors: zouambia m. BMC Neurosci. 2016 Feb 1;17:6. doi: 10.1186/s12868-016-0240-4. BMC Neurosci. 2016. PMID: 26831335 Free PMC article. Clinical Trial.

Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses.

Zouambia M, Fischer DF, Hobo B, De Vos RA, Hol EM, Varndell IM, Sheppard PW, Van Leeuwen FW. Zouambia M, et al. Proteomics. 2008 Mar;8(6):1221-36. doi: 10.1002/pmic.200700679. Proteomics. 2008. PMID: 18283660

Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain.

Fischer DF, De Vos RA, Van Dijk R, De Vrij FM, Proper EA, Sonnemans MA, Verhage MC, Sluijs JA, Hobo B, Zouambia M, Steur EN, Kamphorst W, Hol EM, Van Leeuwen FW. Fischer DF, et al. Among authors: zouambia m. FASEB J. 2003 Nov;17(14):2014-24. doi: 10.1096/fj.03-0205com. FASEB J. 2003. PMID: 14597671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters